Oxford BioMedica (United Kingdom)

193.0k citations
4.7k papers ·

Impact in

Papers in

Oxford BioMedica (United Kingdom)

3.8k papers receiving 149.8k citations

Peers

Oxford BioMedica (United Kingdom)
Comparison fields: 5 of 243
  • Infectious Diseases 19.4k
  • Health Informatics 1.2k
  • Endocrinology, Diabetes and Metabolism 11.2k
  • Immunology 14.3k
  • Hematology 6.7k
Replace Cambridge University Hospitals NHS Foundation Trust with:
Cambridge University Hospitals NHS Foundation Trust United Kingdom
St Mary's Hospital United Kingdom
MRC Clinical Trials Unit at UCL United Kingdom
Royal Brompton Hospital United Kingdom
St. Mary's Hospital United Kingdom
NIHR Imperial Biomedical Research Centre United Kingdom
William Harvey Research Institute United Kingdom
Brighton and Sussex Medical School United Kingdom
Blizard Institute United Kingdom
Leicester Royal Infirmary United Kingdom
Oxford BioMedica (United Kingdom) relative to Cambridge University Hospitals NHS Foundation Trust United Kingdom Cambridge University Hospitals NHS Foundation Trust's profile →
Citations per field
00.5×1.6×
Cambridge University Hospitals NHS Foundation Trust · 1×
Citations per year

Countries citing scholars working at Oxford BioMedica (United Kingdom)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Oxford BioMedica (United Kingdom). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Oxford BioMedica (United Kingdom) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oxford BioMedica (United Kingdom) more than expected).

Fields of papers published by authors at Oxford BioMedica (United Kingdom)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Oxford BioMedica (United Kingdom) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Oxford BioMedica (United Kingdom) at the time of their publication.

About Oxford BioMedica (United Kingdom)

In recent decades, authors affiliated with Oxford BioMedica (United Kingdom) have published 4.7k papers, which have received a total of 193.0k indexed citations . Scholars at this organization have produced 100 papers in Critical Care and Intensive Care Medicine, 226 papers in Hematology, 316 papers in Infectious Diseases, 539 papers in Epidemiology and 332 papers in Immunology on the topics of Asthma and respiratory diseases (132 papers), SARS-CoV-2 and COVID-19 Research (129 papers), Virus-based gene therapy research (124 papers), Immune Cell Function and Interaction (111 papers), Pleural and Pulmonary Diseases (104 papers), Pneumonia and Respiratory Infections (88 papers), Bacterial Infections and Vaccines (87 papers) and Acute Myeloid Leukemia Research (83 papers). Their work is cited by papers focused on Infectious Diseases (19.4k citations), Health Informatics (1.2k citations), Endocrinology, Diabetes and Metabolism (11.2k citations), Immunology (14.3k citations) and Hematology (6.7k citations). Authors at Oxford BioMedica (United Kingdom) collaborate with scholars in United Kingdom, United States and Netherlands and have published in prestigious journals including Nature Communications, BMJ Open, PLoS ONE, Scientific Reports and The Lancet. Some of Oxford BioMedica (United Kingdom)'s most productive authors include Andrew John Pollard, David Richard Matthews, Rury R. Holman, H. A. W. Neil, Mary Angelyn Bethel, Sanjoy Ketan Paul, Nicholas D. Mazarakis, Mark I. McCarthy, Ian Douglas Pavord and Fredrik Karpe.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact